A
Market Data
$1.22−$0.30 (−19.74%)
ATNM · Last trade
Prev Close
$1.52
Range (30d)
$1.22 – $1.46
Recent Filings
- 8-K201.9 KBActinium Pharmaceuticals, Inc.Nov 26, 5:00 PM ET·0001213900-25-115586
- 10-Q4.9 MBActinium Pharmaceuticals, Inc.Nov 14, 4:50 PM ET·0001213900-25-110979
- 10-Q4.4 MBActinium Pharmaceuticals, Inc.Aug 8, 5:00 PM ET·0001213900-25-073743
- 10-Q4.2 MBActinium Pharmaceuticals, Inc.May 9, 5:27 PM ET·0001213900-25-041614
- 8-K240.1 KBActinium Pharmaceuticals, Inc.May 9, 5:00 PM ET·0001213900-25-041582
- 10-K6.8 MBActinium Pharmaceuticals, Inc.Mar 31, 5:00 PM ET·0001213900-25-026371
- 8-K204.5 KBActinium Pharmaceuticals, Inc.Nov 27, 4:30 PM ET·0001213900-24-103498
- 10-Q3.9 MBActinium Pharmaceuticals, Inc.Nov 14, 4:57 PM ET·0001213900-24-098534
- SC 13G/A6.6 KBActinium Pharmaceuticals, Inc.Nov 12, 1:33 PM ET·0000932471-24-000829
- SC 13G/A232.1 KBActinium Pharmaceuticals, Inc.Nov 8, 6:51 PM ET·0000921895-24-002532
Insiders
10- Almenoff June SherieDirector
- Berger Mark StanleyChief Medical Officer
- Chell Jeffrey W.Director
- CICIC DRAGANCOO and CMO
- DAVE KAUSHIK JDirector, President and CEO
- GUAGENTI ENZAChief Financial Officer
- Kapur AnilChief Commercial Officer
- Ludwig Dale L.Chief Scientific Officer
- MAZANET ROSEMARYDirector
- Memorial Sloan Kettering Cancer Center10% Owner
Tickers
Addresses
business
100 PARK AVE., 23RD FLOOR
NEW YORK, NY, 10017
mailing
100 PARK AVE., 23RD FLOOR
NEW YORK, NY, 10017
Former Names
- Cactus Ventures, Inc.2013-03-29